Jake Jorgovan

FEBRUARY 1, 2024

They offer a wealth of expertise in biotechnology, pharmaceuticals, and healthcare, guiding companies through product development, market strategies, and regulatory compliance. The company addresses the challenges faced by pharmaceutical, medical device, biotechnology, and diagnostic firms. market goals for its clients.

Life science 130

Life science Biotech Biotechnology Engineering 130

Jake Jorgovan

JUNE 3, 2024

NDA Partners NDA Partners, a ProPharma Group company, is a leading life sciences management consulting and contract development organization (CDO). They specialize in providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide.

Biopharma 130

Biopharma Biotech Biopharmaceuticals Life science 130

Frost & Sullivan

AUGUST 6, 2023

San Antonio, TX — 7 th Aug, 2023 — Frost & Sullivan recently researched the Asia-Pacific biotechnology contract research organization industry and, based on its findings, recognizes Avance Clinical with the 2023 Customer Value Leadership Award.

Biotechnology 52

Biotechnology Biotech Contract research organization Biopharmaceuticals 52

Frost & Sullivan

JANUARY 30, 2023

SAN ANTONIO – January 30, 2022 – Frost & Sullivan recently analyzed the Asia-Pacific contract research organization industry and, based on its findings, recognizes Novotech with the 2022 Asia-Pacific Contract Research Organization Company of the Year Award.

Biotech 52

Biotech Contract research organization Biotechnology Life science 52

Frost & Sullivan

AUGUST 29, 2024

This is fueling the growing demand for outsourcing, with contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) driving industry growth. Conversely, small-to-mid, and emerging biopharma players, with 1 or 2 molecules in the pipeline, contribute over 16%.

Biopharma 52

Biopharma Biotechnology Contract research organization Utilities 52

Frost & Sullivan

JULY 9, 2024

This technology supports large clientele, small and medium-sized contract research organizations (CROs) and Biotechnology medical device and pharmaceutical companies within the broader life science sector.

Life science 52

Life science Biopharmaceuticals Biotechnology Contract research organization 52

Frost & Sullivan

APRIL 25, 2023

April 25, 2023 – Frost & Sullivan researched the contract research organizations industry and, based on its analysis results, recognizes Emmes with the 2023 Global Competitive Strategy Leadership Award. SAN ANTONIO, TX. The company’s clients include numerous agencies and institutes of the U.S.

Biopharmaceuticals 52

Biopharmaceuticals Biopharma Biotechnology Contract research organization 52